News

Dr. Roy S. Chuck Receives Publication Approval for Amniotic Membrane Immunosuppressive Research

Roy S. Chuck, M.D. Ph.D. (IOP Inc. Medical Director) has received publication approval for his research manuscript detailing the immunosuppressive properties of the AmbioDry2 Amniotic Membrane technology. Continue reading
Posted in News | Leave a comment

IOP Announces the Promotion of Jeffrey Sample to Quality Assurance Supervisor

IOP, Inc., the premier developer and distributor of specialty surgical technologies for eye surgery, announced today the promotion of Jeffrey Sample to Quality Assurance Supervisor. This new appointment is effective immediately. Continue reading
Posted in News | Leave a comment

IOP Launches Second Generation Amniotic Membrane Technology

IOP Inc., the premier developer and distributor of specialty tissue technologies for eye surgery, introduced AmbioDry2™ : the new, improved, generation 2 amniotic membrane technology for eye surgery. Continue reading
Posted in News | Leave a comment

Industry Leaders Added to IOP’s Expanding U.S. Surgical Sales Force

IOP, Inc., the premier developer and distributor of specialty technologies for eye surgery, has added several key industry sales leaders to its expanding domestic surgical sales force. Continue reading
Posted in News | Leave a comment

IOP Announces the Promotion of Daniel Mathot to Assistant Product Manager

IOP, Inc., the premier developer and distributor of specialty surgical technologies for eye surgery, announced today the promotion of Daniel Mathot to Assistant Product Manager. This new appointment is effective immediately. Continue reading
Posted in News | Leave a comment

James Allan Shank Awarded IOP Surgical Rep of the Year for 2004

At the American Academy of Ophthalmology meeting in New Orleans, IOP, Inc. announced the annual recipients for surgical sales performance for 2004. Continue reading
Posted in News | Leave a comment

Dr. Roy Chuck Receives Publication Approvals for AmbioDry Research

Roy Chuck, M.D. Ph.D. (IOP Medical Director) has recently received publication approvals for two research papers detailing the AmbioDry Amniotic Membrane technology. Continue reading
Posted in News | Leave a comment

IOP, Inc. Initiates a National, Multi-Center Clinical Trial for Pioneering Orbital Implant

The new orbital implant consists of a hydrogel sphere to be targeted towards the growing trend towards evisceration as an alternative to enucleation. The advantage of the expanding hydrogel is that the implant is the appropriate size to be placed into the smaller opening of the eviscerated sclera shell. Continue reading
Posted in News | Leave a comment

IOP, Inc. Establishes Commercialization Alliance with Light BioScience, LLC.

IOP Inc., the premier developer and distributor of specialty technologies for eye surgery, announces the alliance formation with Light BioScience LLC for marketing and distribution of skin rejuvenation technology. Continue reading
Posted in News | Leave a comment

IOP Inc. Expands Gold Eyelid Weight Line Through Introduction of Suture Groove Slim™ Technology

IOP Inc., the premier developer and distributor of specialty devices for surgery, announced the introduction of Suture Groove Slim™ Eyelid Gold Weights for surgical treatment of lagophthalmos. Continue reading
Posted in News | Leave a comment